A series of novel 3-aryl-5-pyrrolo[1,2-]imidazole and 5-imidazo[1,2-]azepine quaternary salts were synthesized in 58-85% yields via the reaction of 3-aryl-6, 7-dihydro-5-pyrrolo[1,2-]imidazoles or 3-aryl-6,7,8,9-tetrahydro-5-imidazo[1,2-]azepines and various alkylating reagents. All compounds were characterized by H NMR, C NMR, and LC-MS. The conducted screening studies of the in vitro antimicrobial activity of the new quaternary salts derivatives established that 15 of the 18 newly synthesized compounds show antibacterial and antifungal activity. Synthesized 3-(3,4-dichlorohenyl)-1-[(4-phenoxyphenylcarbamoyl)-methyl]-6,7-dihydro-5-pyrrolo[1,2-]imidazol-1-ium chloride possessed a broad activity spectrum towards , , , , and with a high hemolytic activity against human red blood cells and cytotoxicity against . However, compound is characterized by a low in vivo toxicity in mice (LD > 2000 mg/kg).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305969PMC
http://dx.doi.org/10.3390/molecules26144253DOI Listing

Publication Analysis

Top Keywords

quaternary salts
12
antibacterial antifungal
8
antifungal activity
8
3-aryl-5-pyrrolo[12-]imidazole 5-imidazo[12-]azepine
8
5-imidazo[12-]azepine quaternary
8
activity
5
synthesis antibacterial
4
activity 3-aryl-5-pyrrolo[12-]imidazole
4
salts series
4
series novel
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!